One of the more intriguing findings from our study is that while there was a significant decrease in RelB mRNA in lung fibroblasts from At Risk and COPD subjects (Figure 2), there was no significant change in systemic RelB mRNA levels based on smoking status or airflow limitation (Table 2). This evidence concerns the gene RELB and chronic obstructive pulmonary disease.